BioPharmSignal logoBioPharmSignal

Biotech News

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lifevantage (LFVN)LifevantageCompany update

SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s new President and Chief Executive Officer, under the Company’s 2026

Related news

LFVNLifevantage2026-08-21 12:00 EST

LifeVantage Declares Quarterly Dividend

LFVNLifevantage2026-08-13 20:30 EST

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

View all latest news

Lifevantage

Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants. Nutrigenomics Positioning The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather...

Recent company news

LFVNLifevantage2026-08-21 12:00 EST

LifeVantage Declares Quarterly Dividend

LFVNLifevantage2026-08-13 20:30 EST

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

LFVNLifevantage2026-08-11 21:00 EST

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LFVNLifevantage2026-08-05 20:05 EST

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

LFVNLifevantage2026-08-05 20:05 EST

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

Stock data

Close
6.69 USD
Market cap
108.75M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States